Cardiff Oncology to present cancer drug trial data at ASCO meeting

April 21, 2026 10:00 AM

Cardiff Oncology Inc. (NASDAQ: CRDF) will present updated Phase 2 trial data for its cancer drug onvansertib at the 2026 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found